Adhesive Capsulitis and Dynamic Splinting: a Randomized, Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 5
- 试验地点
- 1
- 主要终点
- Efficacy
研究概览
简要总结
The purpose of this study is to examine the efficacy of dynamic splinting in reducing contracture following diagnosis of adhesive capsulitis.
详细描述
This randomized controlled trial will explore the efficacy of dynamic splinting in conjunction with the current standard of care as compared to standard of care alone.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Greater than 25% reduction in maximal external rotation plus greater than 25% reduction in at least one other plane of motion (elevation or abduction), as compared to the asymptomatic shoulder, measure supine with humerus abducted to 90º
- •Duration from onset less than 12 months.
- •Pain that is worsened by moving the arm in that direction
排除标准
- •Any previous shoulder surgery.
- •Brachial plexus injuries
- •Neurologically mediated pain and fibromatosis-like contracture
- •Concomitant neurologic complaints or abnormalities
- •Glenohumeral impingement or mechanical blockage
- •Oncological process affecting the shoulder
- •Previous total mastectomy
- •Glenohumeral arthritis
研究组 & 干预措施
Dynasplint
Along with standard manual physical therapy, patients will have a stretching device (Dynasplint) used in rehabilitation to regain ROM in stiff joints. Patients will use this device 20-30 minutes 2 times per day at home.
干预措施: Dynasplint (Device)
Dynasplint
Along with standard manual physical therapy, patients will have a stretching device (Dynasplint) used in rehabilitation to regain ROM in stiff joints. Patients will use this device 20-30 minutes 2 times per day at home.
干预措施: Standard of Care (Other)
Control
Patient's in the Physical Therapy Group will have the standard manual treatments during their usual physical therapy visits with no additional intervention
干预措施: Standard of Care (Other)
结局指标
主要结局
Efficacy
时间窗: 6 months
The primary measures are full arc ROM and changes in the Disabilities of the Arm Shoulder Hand pain survey (DASH).
次要结局
未报告次要终点
